Document is current
Any future updates will be listed below
-
Authors
Holman, Wendy
Holman, Wayne
McIntosh, Stacy
Painter, Wendy
Painter, George
Bush, Jim
Cohen, Oren http://orcid.org/0000-0002-6835-3473
- License Information
-
More Information
Article History
Received: 28 April 2021
Accepted: 9 August 2021
First Online: 23 August 2021
Declarations
:
: Refer to reference [CitationRef removed], ExternalRef removed identifier NCT04392219.
: Not applicable.
: Wendy Holman, Wayne Homan, Stacy McIntosh, and Wendy Painter are employees of Ridgeback Biotherapeutics, which funded the study. George Painter holds a number of patents that are relevant to EIDD-2801 (molnupiravir)—see separately submitted ICMJE form. Jim Bush and Oren Cohen are employees of Covance, the CRO chosen by Ridgeback to assist in the execution of the study described.
